Impact BioMedical effects 1-for-12.62 reverse stock split, cuts shares outstanding to about 8.6 million
IBO•Impact BioMedical effected a 1-for-12.62 reverse stock split on Sept. 23, 2026, reducing shares outstanding from about 107.8 million to about 8.6 million.
1. Reverse split details
The split followed board action in November 2025 and stockholder authorization in December 2025. Authorized share counts, par value and voting rights remained unchanged; holders received full shares in lieu of fractional entitlements, and book-entry and broker-held positions were adjusted automatically. The company filed the Nevada charter amendment on Sept. 23, but a clerical processing error delayed the file-stamped copy until Oct. 6.
